Latest Breaking News On - Continued inclusion - Page 1 : comparemela.com

HUTCHMED Announces Continued Inclusion of ELUNATE® (fruquintinib) and SULANDA® (surufatinib) in the National Reimbursement Drug List in China at Current Terms

HUTCHMED Announces Continued Inclusion of ELUNATE® (fruquintinib) and SULANDA® (surufatinib) in the National Reimbursement Drug List in China at Current Terms
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongZhou yiBen atwell alex shawPanmure gordonEli lillyHong chenStock exchange of hong kongNational reimbursement drug listChina limitedChina national healthcare security administrationExchange commissionContinued inclusionSenior vice presidentChief commercial officerSecurities litigation reform act

Investegate |Hutchmed China Ltd Announcements | Hutchmed China Ltd: Updated NRDL to include ELUNATE and SULANDA

Investegate announcements from Hutchmed China Ltd, Updated NRDL to include ELUNATE and SULANDA

Hong kongMark leeZhou yiAtholl tweedie freddy crossleyBen atwell alex shawChristian hoggEli lillyAnnie chengPanmure gordon united kingdomShanghai junshi biosciences co ltdChina limitedEuropean union withdrawalStock exchange of hong kongDrug administrationBeigene ltdChina national healthcare security administration